BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32677844)

  • 1. The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort.
    Ayanian S; Reyes J; Lynn L; Teufel K
    Biomark Med; 2020 Aug; 14(12):1091-1097. PubMed ID: 32677844
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
    Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
    J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
    Poggiali E; Zaino D; Immovilli P; Rovero L; Losi G; Dacrema A; Nuccetelli M; Vadacca GB; Guidetti D; Vercelli A; Magnacavallo A; Bernardini S; Terracciano C
    Clin Chim Acta; 2020 Oct; 509():135-138. PubMed ID: 32531257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
    J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Abnormalities in Pregnant Women with Novel Coronavirus Disease 2019.
    Shi L; Wang Y; Yang H; Duan G; Wang Y
    Am J Perinatol; 2020 Aug; 37(10):1070-1073. PubMed ID: 32396949
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
    Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
    Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.
    Ronderos Botero DM; Omar AMS; Sun HK; Mantri N; Fortuzi K; Choi Y; Adrish M; Nicu M; Bella JN; Chilimuri S
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2764-2775. PubMed ID: 32907371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological features of persons with COVID-19.
    Li Q; Cao Y; Chen L; Wu D; Yu J; Wang H; He W; Chen L; Dong F; Chen W; Chen W; Li L; Ran Q; Liu Q; Ren W; Gao F; Chen Z; Gale RP; Hu Y
    Leukemia; 2020 Aug; 34(8):2163-2172. PubMed ID: 32528042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
    Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 18. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
    Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Rehman MT; Rupert A; Stevens R; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER;
    Lancet Microbe; 2024 Jun; 5(6):e559-e569. PubMed ID: 38815595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
    Gómez-Pastora J; Weigand M; Kim J; Wu X; Strayer J; Palmer AF; Zborowski M; Yazer M; Chalmers JJ
    Clin Chim Acta; 2020 Oct; 509():249-251. PubMed ID: 32579952
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP; Nathan N
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.